On three months follow up, three of four patients had angina class improved from class III to II. One patient had remained in class III angina. The average number of additional nitrate tablets use decreased from 4 to 1.75 per week. Hence, DMR with non-fluoroscopic electromechanical mapping is a safe and feasible revascularization option for patients with end stage coronary artery disease.
PUI-YIN LEE, CHU-PAK LAU, DAVID S W HO, HUNG-FAT TSE, Early Results of Percutaneous Myocardial Revascularization with Three Dimensional Non-fluoroscopic Electromechanical Mapping - A Novel Revascularization Therapy in Patients with End Stage Coronary Artery Disease Journal of the Hong Kong College of Cardiology 2022;8(4):179-184 https://doi.org/10.55503/2790-6744.1388
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.